Access

Article

Nature 432, 466-472 (25 November 2004) | doi:10.1038/nature03000; Received 15 July 2004; Accepted 10 September 2004

Open Innovation Challenges

naturejobs

Thymosin bold beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair

Ildiko Bock-Marquette1,2,5,6, Ankur Saxena1,2,6, Michael D. White3, J. Michael DiMaio3 & Deepak Srivastava1,2,4

  1. Department of Pediatrics, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA
  2. Department of Molecular Biology , University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA
  3. Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA
  4. Children's Medical Center Dallas, 1935 Motor Street, Dallas, Texas 75390, USA
  5. University of Pécs, Faculty of Medicine, Department of Medical Genetics and Child Development, University of Pécs, H-7624 Pécs, Szigeti u.12., Hungary
  6. These authors contributed equally to this work

Correspondence to: Deepak Srivastava1,2,4 Email: Deepak.Srivastava@UTSouthwestern.edu

Top

Heart disease is a leading cause of death in newborn children and in adults. Efforts to promote cardiac repair through the use of stem cells hold promise but typically involve isolation and introduction of progenitor cells. Here, we show that the G-actin sequestering peptide thymosin beta4 promotes myocardial and endothelial cell migration in the embryonic heart and retains this property in postnatal cardiomyocytes. Survival of embryonic and postnatal cardiomyocytes in culture was also enhanced by thymosin beta4. We found that thymosin beta4 formed a functional complex with PINCH and integrin-linked kinase (ILK), resulting in activation of the survival kinase Akt (also known as protein kinase B). After coronary artery ligation in mice, thymosin beta4 treatment resulted in upregulation of ILK and Akt activity in the heart, enhanced early myocyte survival and improved cardiac function. These findings suggest that thymosin beta4 promotes cardiomyocyte migration, survival and repair and the pathway it regulates may be a new therapeutic target in the setting of acute myocardial damage.

  1. Department of Pediatrics, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA
  2. Department of Molecular Biology , University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA
  3. Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA
  4. Children's Medical Center Dallas, 1935 Motor Street, Dallas, Texas 75390, USA
  5. University of Pécs, Faculty of Medicine, Department of Medical Genetics and Child Development, University of Pécs, H-7624 Pécs, Szigeti u.12., Hungary
  6. These authors contributed equally to this work

Correspondence to: Deepak Srivastava1,2,4 Email: Deepak.Srivastava@UTSouthwestern.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Regenerative medicine Prometheus unbound

Nature News and Views (25 Nov 2004)

Research Highlights

Nature Biotechnology News and Views (01 Jan 2005)